Montpellier Network for the Development of Solutions Against Infectious Agents
The REDSAIM project is organized to focus on two complementary activities:
Reconfiguring the A3/L3 part of the structure as an A2-type animal facility provides access to space offering level 2 and 3 containment. This change meets a need for public and private laboratories carrying out research on infectious diseases in various categories. The advantage of a combined A2/L2 - A3/L3 structure is that research can be performed on diseases with different pathologies simultaneously.
The second part of the project, acquiring cutting-edge equipment for the CEMIPAI joint service laboratory, will enable the platform to diversify its service offering for academic and business stakeholders. This varied offering will be made possible notably by the purchase of a super-resolution atomic-force microscope and a sophisticated update of the laboratory's automated screening robot for greater quality control and bar-code referencing.
Montpellier, the international reference in anti-infectious molecule discovery
One of Montpellier's goals is to position itself as an international reference point in the field of anti-infectious molecule discovery to meet the challenges of emerging threats. The project fits in perfectly with that goal, as well as within the framework of the University of Montpellier’s ambitious MUSE I-Site project.
It also corresponds to plans for the Montpellier animal facility network (RAM), which brings together numerous research organizations, including CNRS, INSERM, IRD, and INRA, within a network offering common services.
This is one of the only structures in France able to offer such complete service with respect to fundamental and applied research, and the treatment of infectious diseases.